Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
786.07B
Market cap786.07B
Price-Earnings ratio
70.81
Price-Earnings ratio70.81
Dividend yield
0.65%
Dividend yield0.65%
Average volume
4.36M
Average volume4.36M
High today
$850.00
High today$850.00
Low today
$819.29
Low today$819.29
Open price
$839.51
Open price$839.51
Volume
2.71M
Volume2.71M
52 Week high
$972.53
52 Week high$972.53
52 Week low
$677.09
52 Week low$677.09

LLY News

Quartz 17h
Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions...

Sherwood News 18h
Eli Lilly sues telehealth sites selling copycat Zepbound

The lawsuits target platforms selling compounded versions of name-brand weight-loss drugs even after the government declared a shortage of them was over. Eli L...

Eli Lilly sues telehealth sites selling copycat Zepbound
TipRanks 19h
Lexaria provides GLP-1 update following industry developments

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer (PFE) and by Eli...

Analyst ratings

90%

of 29 ratings
Buy
89.7%
Hold
10.3%
Sell
0%

More LLY News

Benzinga 2d
Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence

Cantor Fitzgerald initiated coverage on Eli Lilly And Co LLY on Monday, citing orforglipron data, which strengthens the case for obesity dominance. Last week,...

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence
Sherwood News 2d
Novo Nordisk slumps following trial results for Eli Lilly's weight-loss pill

Novo Nordisk , the Danish maker of Ozempic and Wegovy, fell almost 10% early on Tuesday — its first trading session since rival Eli Lilly unveiled strong trial...

Novo Nordisk slumps following trial results for Eli Lilly's weight-loss pill
TipRanks 2d
Eli Lilly initiated with an Overweight at Cantor Fitzgerald

As previously reported, Cantor Fitzgerald initiated coverage of Eli Lilly (LLY) with an Overweight rating and $975 price target Lilly is off to “a solid start”...

TipRanks 3d
Novo submits obesity pill for FDA approval, BioPharma Dive reports

Novo Nordisk (NVO) asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this year, a spokesperson...

TipRanks 3d
Eli Lilly & Co: Strong Market Position and Growth Potential with Orforglipron Launch

Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target remains the same w...

TipRanks 4d
Stock Market Weekly Wrap: Eli Lilly Soars, UnitedHealth Crashes, Financials Lead Sector Gains

Last week, the markets wrapped up a shortened trading week (due to Good Friday) with widespread losses, as investors grappled with trade tensions and shifting e...

TipRanks 5d
Eli Lilly’s Stock Soars Amid Promising Drug Trials

Eli Lilly & Co ( (LLY) ) has risen by 11.35%. Read on to learn why. Eli Lilly & Co has seen a significant rise in its stock price, climbing 11.35% over the pas...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.